Please use this identifier to cite or link to this item:
https://doi.org/10.1038/sj.onc.1208541
DC Field | Value | |
---|---|---|
dc.title | p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis | |
dc.contributor.author | Zhu, Z. | |
dc.contributor.author | Mukhina, S. | |
dc.contributor.author | Zhu, T. | |
dc.contributor.author | Mertani, H.C. | |
dc.contributor.author | Lee, K.-O. | |
dc.contributor.author | Lobie, P.E. | |
dc.date.accessioned | 2016-11-28T10:14:32Z | |
dc.date.available | 2016-11-28T10:14:32Z | |
dc.date.issued | 2005-05-26 | |
dc.identifier.citation | Zhu, Z., Mukhina, S., Zhu, T., Mertani, H.C., Lee, K.-O., Lobie, P.E. (2005-05-26). p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis. Oncogene 24 (23) : 3774-3785. ScholarBank@NUS Repository. https://doi.org/10.1038/sj.onc.1208541 | |
dc.identifier.issn | 09509232 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/130949 | |
dc.description.abstract | Previous microarray expression analyses have indicated autocrine human growth hormone (hGH) regulation of genes involved in the oxidative stress response. Expression analysis of antioxidant enzymes revealed that autocrine hGH increased both the mRNA and protein levels of catalase, superoxide dismutase 1 (SOD1), glutathione peroxidase and glutamylcysteine synthetase but not that of SOD2. As a consequence, autocrine hGH increased the antioxidant capacity of mammary carcinoma cells and protected against oxidative stress-induced apoptosis. Catalase activity was increased by autocrine production of hGH in mammary carcinoma cells and a catalase inhibitor abrogated protection from oxidative stress afforded by autocrine hGH. Autocrine hGH transcriptionally regulated catalase gene expression in a p44/42 MAP kinase-dependent manner and inhibition of MEK concordantly abrogated the protective effect of autocrine hGH against oxidative stress-induced apoptosis. Given that increased cellular oxidative stress is a key effector mechanism of specific chemotherapeutic agents, we propose that antagonism of autocrine hGH will improve the efficacy of chemotherapeutic regimes utilized for human mammary carcinoma. © 2005 Nature Publishing Group All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1038/sj.onc.1208541 | |
dc.source | Scopus | |
dc.subject | Autocrine | |
dc.subject | Catalase | |
dc.subject | Growth hormone | |
dc.subject | Mammary carcinoma | |
dc.subject | Oxidative stress | |
dc.type | Article | |
dc.contributor.department | MEDICINE | |
dc.description.doi | 10.1038/sj.onc.1208541 | |
dc.description.sourcetitle | Oncogene | |
dc.description.volume | 24 | |
dc.description.issue | 23 | |
dc.description.page | 3774-3785 | |
dc.description.coden | ONCNE | |
dc.identifier.isiut | 000229346300008 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
SCOPUSTM
Citations
35
checked on Mar 2, 2021
WEB OF SCIENCETM
Citations
36
checked on Mar 2, 2021
Page view(s)
51
checked on Feb 27, 2021
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.